Greg Silvesti

Greg Silvesti has extensive experience in the field of digital health and innovation. Greg currently holds the position of Vice President at Sage Therapeutics since July 2022, where they are responsible for leading digital health and innovation initiatives. Prior to this, they served as the Executive Director and Head of Digital Health & Innovation at Sage Therapeutics from June 2021 to July 2022.

Before joining Sage Therapeutics, Greg worked at AbbVie as the Head of Digital Health & Innovation from June 2018 to June 2021. Greg also held the role of Director of Digital Health & Devices at Teva Pharmaceuticals from May 2015 to June 2018.

Greg gained valuable experience as Director of WW Customer Insights at Bristol-Myers Squibb from May 2013 to May 2015. Prior to this, they worked at LifeScan Inc., a Johnson & Johnson Company, as the GSM of Innovation & New Product Development from June 2010 to May 2013.

Greg began their career at NAXION in August 2002, where they served as an Associate Group Director of Research & Consulting until June 2010.

Overall, Greg Silvesti's work experience spans over two decades and includes leadership roles in digital health and innovation within the pharmaceutical and healthcare industry.

Greg Silvesti holds a Bachelor of Arts (BA) degree in Business Administration from Muhlenberg College. Greg also pursued further education at the Fox School of Business at Temple University, where they completed a Master of Business Administration (MBA) degree with a focus on Marketing Management.